Top

Published in:

Open Access 01-12-2018 | Protocol

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol

Authors: Nitika Sanger, Meha Bhatt, Laura Zielinski, Stephanie Sanger, Hamnah Shahid, Bianca Bantoto, M.Constantine Samaan, Russell de Souza, Zainab Samaan

Published in: Systematic Reviews | Issue 1/2018

Abstract

Background

In North America, opioid use has become a public health crisis with policy makers declaring it a state of emergency. Opioid substitution therapy (OST) is a harm-reduction method used in treating opioid use disorder. While OST has shown to be successful in improving treatment outcomes, there is still a great degree of variability among patients. This cohort of patients has shifted from young males using heroin to a greater number of older people and women using prescription opioids. The primary objective of this review is to examine the literature on the association between the first exposure to opioids through prescription versus illicit use and OST treatment outcomes.

Method

An electronic search will be conducted on the EMBASE, MEDLINE, PsycINFO, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases. Two independent reviewers will conduct the initial title and abstract screenings using predetermined criteria for inclusion and exclusion. Reviewers will then conduct full-text data extraction using a pilot-tested data extraction form in duplicate. A third author will resolve disagreements if consensus cannot be reached. Quality and risk of bias assessment will be conducted along with a sensitivity analysis for all included studies. Qualitative summary of the evidence will be provided, and when possible, a meta-analysis will be conducted, along with heterogeneity calculation. The reporting of this protocol follows the PRISMA-P.

Discussion

We expect that this review will help determine whether patients that were initially exposed to opioids through a prescription differ in OST treatment outcomes in comparison to people who used opioids through illicit means. We hope that this review will provide evidence related to prescription opioids exposure and future treatment outcomes, which will aid clinicians in their decisions to prescribe opioids or not for specific populations at risk.

Systematic review registration

PROSPERO CRD42017058143

Available only for authorised users

UNODC. World drug report 2015 [Internet], vol. 53: United Nations publication; 2015. p. 1689–99. Available from: https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf.

American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub. Washington, DC.

Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, El-Guebaly N, et al. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Heal. 2005;82(2):250–66.CrossRef

Bertschy G. Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci. 1995;245(2):114–24.CrossRefPubMed

Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. Centers Dis Control Prev MMWR. 2016;64:1378–82.

Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70.CrossRefPubMed

Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLoS One [Internet]. 2013;8(2):e54496. Available from: https://doi.org/10.1371/journal.pone.0054496CrossRef

Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.

Bawor M, Dennis BB, Varenbut M, Daiter J, Marsh DC, Plater C, et al. Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biol Sex Differ. 2015;6(1):21.CrossRefPubMedPubMedCentral

10.

Zhong W, Maradit-Kremers H, Sauver JLS, Yawn BP, Ebbert JO, Roger VL, Jacobson DJ, McGree ME, Brue SM, Rocca WA. Age and sex patterns of drug prescribing in a defined American population. In Mayo Clinic Proceedings (Vol. 88, No. 7, pp. 697-707). Elsevier; 2013.

11.

Darnall BD, Stacey BR, Chou R. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med. 2012;13(9):1181–211.CrossRefPubMedPubMedCentral

12.

Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357–68.CrossRefPubMed

13.

Darke S, Marel C, Slade T, Ross J, Mills KL, Teesson M. Patterns and correlates of sustained heroin abstinence: findings from the 11-year follow-up of the Australian treatment outcome study. J Stud Alcohol Drugs. 2015;76(6):909–15.CrossRefPubMed

14.

Wright NMJ, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, et al. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial. Br J Gen Pr. 2011;61(593):e772–80.CrossRef

15.

Park TW, Cheng DM, Lloyd-Travaglini CA, Bernstein J, Palfai TP, Saitz R. Changes in health outcomes as a function of abstinence and reduction in illicit psychoactive drug use: a prospective study in primary care. Addiction. 2015;110(9):1476–83.CrossRefPubMedPubMedCentral

16.

Li Y, Kantelip J-P, Gerritsen-van Schieveen P, Davani S. Interindividual variability of methadone response. Mol Diagn Ther. 2008;12(2):109–24.CrossRefPubMed

17.

Hurley RW, MCB A. Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008;107(1):309.CrossRefPubMedPubMedCentral

18.

Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39(1):1–23.CrossRefPubMed

19.

Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O’Connor PG, et al. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med. 2007;22(4):527–30.CrossRefPubMedPubMedCentral

20.

Nielsen S, Hillhouse M, Mooney L, Fahey J, Ling W. Comparing buprenorphine induction experience with heroin and prescription opioid users. J Subst Abus Treat. 2012;43(3):285–90.CrossRef

21.

Setnik B, Roland CL, Sommerville KW, Pixton GC, Berke R, Calkins A, et al. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res. 2015;8:361.PubMedPubMedCentral

22.

Højsted J, Ekholm O, Kurita GP, Juel K, Sjøgren P. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain. 2013;154(12):2677–83.CrossRefPubMed

23.

Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, et al. Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat. 2014;10:2239.PubMedPubMedCentral

24.

Orwin RG, Vevea JL. Evaluating coding decisions. Handb Res Synth meta-analysis. 2009;2:177–203.

25.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.CrossRefPubMedPubMedCentral

26.

Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009. Epub Available from URL http//www ohri ca/programs/clinical_epidemiology/oxford htm [cited 2009 Oct 19]. 2013;

27.

Bawor M, Dennis BB, Anglin R, Steiner M, Thabane L, Samaan Z. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Syst Rev. 2014;3(1):45.CrossRefPubMedPubMedCentral

28.

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentral

29.

Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from http://handbook.cochrane.org.

30.

Guyatt GH, Oxman AD, Schünemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380–2.CrossRefPubMed

31.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.CrossRefPubMedPubMedCentral

Title: Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
Authors: Nitika Sanger
Meha Bhatt
Laura Zielinski
Stephanie Sanger
Hamnah Shahid
Bianca Bantoto
M.Constantine Samaan
Russell de Souza
Zainab Samaan
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: Systematic Reviews / Issue 1/2018
Electronic ISSN: 2046-4053
DOI: https://doi.org/10.1186/s13643-018-0682-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol

Abstract

Background

Method

Discussion

Systematic review registration

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Method

Discussion

Systematic review registration

Please log in to get access to this content

Other articles of this Issue 1/2018

Drug discontinuation before contrast procedures and the effect on acute kidney injury and other clinical outcomes: a systematic review protocol

Functional, motor, and sensory assessment instruments upon nerve repair in adult hands: systematic review of psychometric properties

Interventions for behaviour change and self-management in stroke secondary prevention: protocol for an overview of reviews.

Comparative effectiveness of physical activity interventions and anti-hypertensive pharmacological interventions in reducing blood pressure in people with hypertension: protocol for a systematic review and network meta-analysis

Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)

Making progress with the automation of systematic reviews: principles of the International Collaboration for the Automation of Systematic Reviews (ICASR)